KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - Net
Ratios

Neogenomics (NEO) Accumulated Depreciation & Amortization (2016 - 2025)

Neogenomics (NEO) has disclosed Accumulated Depreciation & Amortization for 13 consecutive years, with $190.0 million as the latest value for Q4 2024.

  • For the quarter ending Q4 2024, Accumulated Depreciation & Amortization rose 20.09% year-over-year to $190.0 million, compared with a TTM value of $190.0 million through Dec 2024, up 20.09%, and an annual FY2024 reading of $190.0 million, up 20.09% over the prior year.
  • Accumulated Depreciation & Amortization was $190.0 million for Q4 2024 at Neogenomics, up from $158.2 million in the prior quarter.
  • Across five years, Accumulated Depreciation & Amortization topped out at $190.0 million in Q4 2024 and bottomed at $25.9 million in Q4 2020.
  • Average Accumulated Depreciation & Amortization over 5 years is $123.2 million, with a median of $131.9 million recorded in 2022.
  • The sharpest move saw Accumulated Depreciation & Amortization skyrocketed 324.46% in 2021, then increased 19.92% in 2023.
  • Year by year, Accumulated Depreciation & Amortization stood at $25.9 million in 2020, then surged by 324.46% to $110.0 million in 2021, then grew by 19.99% to $131.9 million in 2022, then rose by 19.92% to $158.2 million in 2023, then grew by 20.09% to $190.0 million in 2024.
  • Business Quant data shows Accumulated Depreciation & Amortization for NEO at $190.0 million in Q4 2024, $158.2 million in Q4 2023, and $131.9 million in Q4 2022.